Journal
ACS NANOSCIENCE AU
Volume 2, Issue 4, Pages 355-366Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsnanoscienceau.1c00044
Keywords
controlled drug release; erlotinib derivative; EGFR-positive cells; harmonic nanoparticles; light-triggered uncaging; second harmonic generation; surface functionalization
Categories
Funding
- Interreg V Program (NANO-FIMT grant)
- Interreg V Program (OncoNanoScreen grant)
- Swiss National Science Foundation [200021E_205745]
- Swiss National Science Foundation (SNF) [200021E_205745] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
This study presents a nanoparticle-based drug delivery system that increases the efficiency of chemotherapy by accumulating drugs at specific target sites, reducing adverse side effects and patient resistance. The system utilizes photo-responsive nanomaterials to release drugs upon light irradiation. The results show promising capabilities for the treatment of mas.
Nanoparticle-based drug delivery systems have the potential for increasing the efficiency of chemotherapeutics by enhancing the drug accumulation at specific target sites, thereby reducing adverse side effects and mitigating patient acquired resistance. In particular, photo-responsive nanomaterials have attracted much interest due to their ability to release molecular cargos on demand upon light irradiation. In some settings, they can also provide complementary information by optical imaging on the (sub)cellular scale. We herein present a system based on lithium niobate harmonic nanoparticles (LNO HNPs) for the decoupled multi-harmonic cell imaging and near-infrared light-triggered delivery of an erlotinib derivative (ELA) for the treatment of mas. The ELA cargo was covalently conjugated to the surface of silica-coated LNO HNPs through a coumarinyl photo-cleavable linker, achieving a surface loading of the active molecule of 27 nmol/mg NPs. The resulting nanoconjugates (LNO-CM-ELA NPs) were successfully imaged upon pulsed laser excitation at 1250 nm in EGFR-overexpressing human prostate cancer cells DU145 by detecting the second harmonic emission at 625 nm, in the tissue transparency window. Tuning the laser at 790 nm resulted in the uncaging of the ELA cargo as a result of the second harmonic emission of the inorganic HNP core at 395 nm. This protocol induced a significant growth inhibition in DU145 cells, which was only observed upon specific irradiation at 790 nm, highlighting the promising capabilities of LNO-CM-ELA NPs for theranostic applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available